UPC_APP_47163/2024

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Procedural & sub-applicationsDocument Access (RoP262)Munich CDGenericWritten Phase

2024-10-22Procedural onlyproceduralApplication RoP262.1 (b)
Order from the Central Division Munich (UPC_CFI_1/2023) on Dehns' application under R. 262.1(b) RoP for access to all written pleadings and evidence in the combined revocation and counterclaim for revocation proceedings (Sanofi v Amgen, EP 3 666 797). The Court granted partial access to case documents, subject to conditions proposed by Sanofi, to enable Dehns, a firm of UPC representatives, to better understand the Court's procedures.